Abstract
Clinical evaluation provides the necessary evidence that healthcare interventions are safe, effective, and likely to bring benefit to patients and healthcare system. While a large volume of evidence for in silico performance of AI systems has been published in recent years, prospective clinical trials are only just beginning to emerge. This chapter presents a summary of prospective randomized trials published in AI health interventions to date and discusses new AI-specific reporting standards for clinical evaluations.
| Original language | English |
|---|---|
| Title of host publication | Artificial Intelligence in Medicine |
| Editors | Niklas Lidströmer, Hutan Ashrafian |
| Publisher | Springer International Publishing Cham |
| Pages | 645-660 |
| Number of pages | 16 |
| ISBN (Electronic) | 9783030645731 |
| ISBN (Print) | 9783030645724 |
| DOIs | |
| Publication status | Published - 18 Feb 2022 |
Bibliographical note
Publisher Copyright:© Springer Nature Switzerland AG 2022.
ASJC Scopus subject areas
- General Medicine
- General Biochemistry,Genetics and Molecular Biology
Fingerprint
Dive into the research topics of 'Clinical Evaluation of AI in Medicine'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver